Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-06-09 07:52 am Purchase | 13G | CARDLYTICS INC CDLX | WELLINGTON MANAGEMENT GROUP LLP | 3,766,240 11.46% | 1,959,449 (+108.45%) | View |
| 2021-02-16 5:31 pm Purchase | 13G | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 4,488,972 16.3% | 474,723 (+11.83%) | View |
| 2021-02-10 10:39 am Purchase | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 1,836,743 6.69% | 1,836,743 (New Position) | View |
| 2021-02-03 2:14 pm Purchase | 13G | CARDLYTICS INC CDLX | WELLINGTON MANAGEMENT GROUP LLP | 1,806,791 6.58% | 113,301 (+6.69%) | View |
| 2021-02-02 3:16 pm Purchase | 13G | CARDLYTICS INC CDLX | BlackRock Inc. BLK | 2,048,867 7.5% | 2,048,867 (New Position) | View |
| 2021-01-08 11:43 am Purchase | 13G | CARDLYTICS INC CDLX | JPMORGAN CHASE & CO JPM | 1,380,863 5% | 1,380,863 (New Position) | View |
| 2020-05-11 08:44 am Sale | 13G | CARDLYTICS INC CDLX | FMR LLC | 542,784 2.013% | -1,866,504 (-77.47%) | View |
| 2020-04-10 9:06 pm Purchase | 13G | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 4,014,249 15% | 1,192,539 (+42.26%) | View |
| 2020-03-10 09:40 am Sale | 13G | CARDLYTICS INC CDLX | FMR LLC | 2,409,288 9.37% | -1,447,468 (-37.53%) | View |
| 2020-02-14 1:54 pm Purchase | 13G | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 2,821,710 11% | 331,317 (+13.30%) | View |
| 2020-02-14 1:04 pm Sale | 13G | CARDLYTICS INC CDLX | FRONTIER CAPITAL MANAGEMENT CO LLC | 332,780 1.3% | -1,129,997 (-77.25%) | View |
| 2020-02-12 4:34 pm Sale | 13G | CARDLYTICS INC CDLX | Polaris Venture Partners V L.P. | 9,010 0% | -2,543,616 (-99.65%) | View |
| 2020-02-07 11:16 am Purchase | 13G | CARDLYTICS INC CDLX | FMR LLC | 3,856,756 14.999% | 645,031 (+20.08%) | View |
| 2020-02-06 1:50 pm Sale | 13G | CARDLYTICS INC CDLX | PRUDENTIAL FINANCIAL INC PRU | 555,623 2.2% | -709,381 (-56.08%) | View |
| 2020-02-06 08:22 am Sale | 13G | CARDLYTICS INC CDLX | Canaan VIII LP | 0 0% | -2,368,141 (Position Closed) | View |
| 2020-02-04 2:20 pm Sale | 13G | CARDLYTICS INC CDLX | JENNISON ASSOCIATES LLC | 482,290 1.9% | -782,064 (-61.85%) | View |
| 2020-01-28 09:57 am Purchase | 13G | CARDLYTICS INC CDLX | WELLINGTON MANAGEMENT GROUP LLP | 1,693,490 6.59% | 1,693,490 (New Position) | View |
| 2019-10-22 3:24 pm Sale | 13G | CARDLYTICS INC CDLX | Aimia Inc. | 1,098,410 4.52% | -379,604 (-25.68%) | View |
| 2019-10-15 6:02 pm Purchase | 13G | CARDLYTICS INC CDLX | CAS Investment Partners LLC | 2,490,393 10.1% | 1,117,891 (+81.45%) | View |
| 2019-08-28 3:49 pm Purchase | 13G | CARDLYTICS INC CDLX | Aimia Inc. | 1,478,014 6.47% | 1,478,014 (New Position) | View |